-
CCHIO 2024丨Dr. Jianqing Zhu：Precision Diagnosis and Treatment of Platinum-Resistant Recurrent Ovarian Cancer
In the historic city of Xi’an, renowned for its cultural significance, the 2024 Chinese Congress of Holistic Integrative Oncology (CCHIO) and the Asian Oncology Society (AOS) took place from November 14 to 17, creating a global platform for the oncology community. During the CCHIO’s gynecological oncology session, Dr. Jianqing Zhu from Zhejiang Cancer Hospital presented…
-
CCHIO 2024丨Academician Daiming Fan: Integrative Medicine Ushers in a New Era of Cancer Prevention and Treatment
The 2024 Chinese Congress of Holistic Integrative Oncology (CCHIO) opened grandly in the ancient city of Xi’an on November 16, focusing on the theme “Winning Against Cancer Through Integration.” This conference brought together global medical elites to strategize for global health solutions. During the event, conference chair and President of the China Anti-Cancer Association (CACA),…
-
CTI 2024丨Dr. He Huang: Exploring Frontiers and Inspiring the Future—In-depth Analysis of the Highlights of the 2024 Cellular Therapy and Immunotherapy
From November 14 to 17, 2024, the Cellular Therapy and Immunotherapy (CTI) Conference was held in Hangzhou, China. Jointly organized by Zhejiang University, the International Academy for Clinical Hematology (IACH), the Asian Cellular Therapy Organization (ACTO), the Zhejiang Immunological Society, and Cell Research, this grand event was supported by The First Affiliated Hospital of Zhejiang…
-
CTI 2024丨Dr. Peihua Lu: A Global Vision with Local Wisdom – Pioneering CAR-T Therapy for T-Cell Malignancies
From November 14 to 17, 2024, the Cellular Therapy and Immunotherapy (CTI) Conference was held in Hangzhou, China, bringing together leading global experts, scholars, and industry leaders in the field of cell and immunotherapy. This conference served not only as a platform for academic exchange but also as a vital window to showcase cutting-edge research…
-
CCHIO 2024丨CHINA-AFRICA Summit: Advancing Cancer Research through Deepened Collaboration
The 2024 Chinese Congress of Holistic Integrative Oncology (CCHIO) and the 4th Asian Oncology Society (AOS), hosted by the China Anti-Cancer Association (CACA), and co-organized by the Institute for Development Strategy of Holistic Integrative Medicine and Shaanxi Anti-Cancer Association, was grandly held in the ancient capital of Xi’an from November 14th to 17th. During this…
-
CCHIO 2024丨Dr. Wenxing Qin: Advances in Breast Cancer Treatment—New Drugs and Multimodal Therapies Pioneering Personalized Precision Medicine
In the battle against breast cancer, every physician is a bold explorer, extending the boundaries of life through innovation and dedication. Their efforts not only save lives in the clinic but also drive progress in research, contributing to more precise and effective treatments for breast cancer patients. During the 2024 Chinese Congress of Holistic Integrative…
-
Chinese Contributions at AASLD 2024: Dr. Yanyan Yu and Dr. Jinghang Xu’s Team Reveal Clinical Features and Prognostic Factors of HBV-Associated Glomer
Study 1: High Proportion of HBsAg-Negative Patients in HBV-GN: A Retrospective Cohort Study HBV-GN, a prevalent secondary glomerular disease in China, has traditionally been associated with positive HBsAg. However, recent…
-
CCHIO 2024丨Dr. Chunfang Hao: Advances in Breast Cancer Precision Treatment—Target Selection and Drug Innovation
Breast cancer remains one of the most significant threats to women’s health. The continuous evolution of treatment strategies reflects the rapid advancement of medical technology. In recent years, precision treatment for breast cancer has become a focal point of research, with accurate target selection and innovative drug development being of paramount importance. At the 2024…
Connecting Medical Expertise through Media